Tissue Regenix Group plc Overview

Tissue Regenix Group plc Cost of Revenue

Cost of Revenue analysis for TSSNF.

Quarterly Cost of Revenue

$6.15M

↑ 5.79% YoY

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$24.26M

↑ 36.29% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin